Biology subjects

Komada, T.

Publications and source records attributed to Komada, T..

3 recordsLinked to original sources

bioRxiv2026

Inflammasome activation drives gasdermin-independent plasma membrane rupture by clustering ninjurin-1 in macrophages

Inflammasome assembly rapidly triggers caspase-1 activation to initiate pyroptosis, an inflammatory cell death characterized by the release of cytosolic contents, including interleukin (IL)-1{beta}/. Here, we report that inflammasome activation drives necrotic cell death independent of gasdermin D (GSDMD) and GSDME, which are essential executors of pyroptosis by forming a pore on the plasma membrane and increasing membrane permeability. NLRP3 inflammasome activation induced necrotic cell death, coupled with IL-1{beta}/ release in Gsdmd-/-Gsdme-/- macrophages. Mechanistically, the oligomerization of ninjurin-1 (NINJ1) was caused by inflammasome activation even in the absence of GSDMD and GSDME. Concordantly, glycine, an inhibitor of NINJ1, blocked plasma membrane permeabilization triggered by inflammasome activation in Gsdmd-/-Gsdme-/- macrophages, but not in WT macrophages. The dimerizer-mediated ASC oligomerization promoted NINJ1-mNeonGreen cluster formation in the absence of GSDMD and GSDME. Moreover, NINJ1 deficiency prevented membrane permeabilization initiated by ASC oligomerization in Gsdmd-/-Gsdme-/- immortalized bone marrow-derived macrophages (iBMDM). Blocking of phosphatidylserine (PtdSer) exposure, a feature of inflammasome-driven necrotic cell death, by Xkr8 deficiency inhibited plasma membrane permeabilization in Gsdmd-/-Gsdme-/- iBMDM. These results suggest that inflammasome-triggered activation of caspase-1 itself drives inflammatory necrotic cell death independent of gasdermins.

cell biology↗

bioRxiv2022

DHCR7 as a novel regulator of ferroptosis in hepatocytes

Recent evidence indicates that ferroptosis is implicated in the pathophysiology of various liver diseases; however, the mechanism of ferroptosis regulation in the liver is poorly understood. Here, using the whole-genome screening approach, we identified 7-dehydrocholesterol reductase (DHCR7), the terminal enzyme of cholesterol biosynthesis, as a novel regulator of ferroptosis in hepatocytes. Genetic and pharmacological inhibition (with AY9944) of DHCR7 suppressed lipid peroxidation and ferroptosis in human hepatocellular carcinoma Huh-7 cells. DHCR7 inhibition increased its substrate, 7-dehydrocholesterol (7-DHC), and extrinsic 7-DHC supplementation in turn suppressed ferroptosis. On the other hand, cholesterol deprivation had no effect on ferroptosis. A 7-DHC-derived oxysterol metabolite, 3{beta},5-dihydroxycholest-7-en-6-one (DHCEO), was increased by a ferroptosis inducer RSL-3 in DHCR7-deficient cells, suggesting that the ferroptosis-suppressive effect of DHCR7 inhibition was driven by intracellular 7-DHC as a radical scavenger. While extrinsic 7-DHC supplementation suppressed ferroptosis in various cancer cells, pharmacological DHCR7 inhibition by AY9944 showed cell-type specific effects, which could be explained by high DHCR7 expression in Huh-7 cells. We further showed that AY9944 suppressed ferroptosis in murine primary hepatocytes in vitro and systemic administration of AY9944 inhibited hepatic ischemia-reperfusion injury in vivo. These findings provide new insights into the regulatory mechanism of liver ferroptosis and suggest that DHCR7 inhibition is a potential therapeutic option for ferroptosis-related liver diseases.

molecular biology↗

bioRxiv2021

Cryo-sensitive aggregation triggers NLRP3 inflammasome assemblyin cryopyrin-associated periodic syndrome

Cryopyrin-associated periodic syndrome (CAPS) is an autoinflammatory syndrome caused by mutations of NLRP3, which was originally identified as cryopyrin. Familial cold autoinflammatory syndrome (FCAS), the mildest form of CAPS, is characterized by cold-induced inflammation induced by the overproduction of IL-1{beta}. However, the molecular mechanism of how mutated NLRP3 causes inflammasome activation in CAPS remains unclear. Here, we found that CAPS-associated NLRP3 mutants form cryo-sensitive aggregates that function as a scaffold for inflammasome activation. Cold exposure promoted inflammasome assembly and subsequent IL-1{beta} release triggered by mutated NLRP3. While K+ efflux was dispensable, Ca2+ was indispensable for mutated NLRP3-mediated inflammasome assembly. Notably, Ca2+ influx was induced during mutated NLRP3-mediated inflammasome assembly. Furthermore, caspase-1 inhibition prevented Ca2+ influx and inflammasome assembly induced by the mutated NLRP3, suggesting a feed-forward Ca2+ influx loop triggered by mutated NLRP3. Thus, the mutated NLRP3 forms cryo-sensitive aggregates to promote inflammasome assembly distinct from canonical NLRP3 inflammasome activation.

immunology↗